TCM
CBAY
TCG Crossover Management’s Cymabay Therapeutics CBAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,048,257
| Closed | -$26.6M | – | 24 |
|
|
2023
Q1 | $26.6M | Sell |
3,048,257
-2,857,143
| -48% | -$24.9M | 5.18% | 8 |
|
|
2022
Q4 | $37M | Hold |
5,905,400
| – | – | 6.53% | 4 |
|
|
2022
Q3 | $20.7M | Hold |
5,905,400
| – | – | 6.2% | 6 |
|
|
2022
Q2 | $17.4M | Hold |
5,905,400
| – | – | 7.4% | 5 |
|
|
2022
Q1 | $18.4M | Hold |
5,905,400
| – | – | 7.37% | 6 |
|
|
2021
Q4 | $20M | Buy |
+5,905,400
| New | +$20M | 9.35% | 4 |
|